Michael Thomas Heffernan, Director at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 50,000 shares at $13.13 ($642K) on 2019-05-15, disclosed to the SEC on 2019-05-17.
Open-market sale of $642k COLL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.74 | 18,483 | $235K | 36.7% |
| 2 | $12.74 | 18,483 | $235K | 36.7% |
| 3 | $13.13 | 6,517 | $86K | 13.3% |
| 4 | $13.13 | 6,517 | $86K | 13.3% |
| Total | $12.84 avg | 50,000 | $642K | 100% |
| Filing → |
| COLL | SELL | 2022-12-14 | $8.4M | — | Filing → |
| COLL | SELL | 2021-03-17 | $2.5M | — | Filing → |
| COLL | SELL | 2020-08-12 | $500K | — | Filing → |